Issued Patents All Time
Showing 1–25 of 94 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12350269 | Cerdulatinib for the treatment of b-cell malignancies | Gregory Coffey, Janet M. Leeds | 2025-07-08 |
| 12233032 | Compositions for management of polycystic ovary syndrome | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani | 2025-02-25 |
| 12122785 | Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors | Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy +1 more | 2024-10-22 |
| 12115154 | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) | Simeon Bowers, Mark Karbarz, Jiang Zhu, Thomas E. Barta, Jonathan William Bourne | 2024-10-15 |
| 12103937 | Substituted pyridines and pyridazines as TYK2 inhibitors | Gregory Dietsch, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh KALVA | 2024-10-01 |
| 12084458 | Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors | Gregory Dietsch, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh KALVA | 2024-09-10 |
| 11944619 | Phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2024-04-02 |
| 11945782 | Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2024-04-02 |
| 11925606 | Compositions for managing chronic obstructive pulmonary disease | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani | 2024-03-12 |
| 11925637 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2024-03-12 |
| 11891369 | Compounds for binding proprotein convertase subtilisin/kexin type 9 | Simeon Bowers, Thomas E. Barta, Jonathan William Bourne | 2024-02-06 |
| 11744807 | Therapeutic compositions and methods for pulmonary fibrosis | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani | 2023-09-05 |
| 11613548 | Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors | Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy +1 more | 2023-03-28 |
| 11414410 | Inhibitors of protein kinases | Shawn M. Bauer, Zhaozhong J. Jia, Mukund Mehrotra, Yonghong Song, Qing Xu +3 more | 2022-08-16 |
| 11413318 | Compositions and methods for management of atrophic gastritis and colitis | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Shaheen Majeed | 2022-08-16 |
| 11266645 | Methods for treating lymphoma | Gregory Coffey, Matthew Birrell, Pamela B. Conley, John T. Curnutte, Andrew Steele +1 more | 2022-03-08 |
| 11098040 | Compounds and methods of use | Chun Jiang, Ruihong Chen, Biswajit Kalita, Athisayamani Jeyaraj Duraiswamy | 2021-08-24 |
| 11052125 | Compositions for weight loss | Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur, Sarang Bani | 2021-07-06 |
| 11040964 | Compounds and methods of use | Chun Jiang, Ruihong Chen, Biswajit Kalita, Athisayamani Jeyaraj Duraiswamy | 2021-06-22 |
| 10980801 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2021-04-20 |
| 10865185 | Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2020-12-15 |
| 10864243 | Composition for prostaglandin transporter inhibition and related therapeutic applications | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani | 2020-12-15 |
| 10864242 | Aphrodisiac composition and management of male sexual dysfunction | Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani | 2020-12-15 |
| 10821106 | Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2020-11-03 |
| 10568882 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers | 2020-02-25 |